Clinical Trial Update: BIOFLOW-china Post-marketing Study (BIOTRONIK)

View source ↗

Summary

The BIOFLOW-china post-marketing study for Biotronik coronary stents has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Stenosis
• In-stent Restenosis

Snippet

Sponsor: Biotronik (Beijing) Medical Device Ltd. | Conditions: In-Stent Stenosis (Restenosis) of Coronary Artery Stent, Native Coronary Artery Stenosis | Status: TERMINATED